High-volume centers achieve superior outcomes in left ventricular assist device explant-heart transplantation

<h2>Abstract</h2><h3>Background</h3> Left ventricular assist device <b>(</b>LVAD) explantation at the time of orthotopic heart transplantation (OHT) carries increased perioperative risks. This study examined whether institutional operative volume influences outcomes following LVAD explant-OHT in a contemporary national cohort. <h3>Methods</h3> Adult patients who underwent LVAD explantation with OHT between 2011 and 2024 were identified in the Organ Procurement and Transportation Network/United Network for Organ Sharing registry. Using a rank-order method based on surgical volume, centers were stratified as either high volume or low volume. The primary outcome was 1-year survival; secondary outcomes included graft failure, ischemic time, dialysis, stroke, and hospital length of stay. Kaplan-Meier and Cox regression analyses were performed to assess survival and predictors of mortality. <h3>Results</h3> A total of 2863 patients across 121 centers were analyzed. Eight high-volume centers performed 31.3% (897 cases) of all LVAD explant-OHTs. Baseline characteristics, including heart failure etiology and LVAD device type, were similar in the 2 groups. High-volume centers demonstrated decreased ischemic time (mean, 3.1 ± 1.3 hours vs 3.5 ± 1.4 hours; <i>P</i> < .001), a lower rate of postoperative dialysis (12.7% vs 15.4%; <i>P</i> = .023), and shorter length of stay (mean, 22.8 ± 26.6 days vs 25.9 ± 31.3 days; <i>P</i> = .006) compared to low-volume centers. Graft failure was less common at high-volume centers (24.2% vs 28.8%; <i>P</i> = .011). One-year survival rate (81.6% vs 76.1%; <i>P</i> = .001) and median survival (4.93 years vs 4.00 years; <i>P</i> = .018) were greater at high-volume centers. Multivariable analysis identified low-volume center status as an independent predictor of higher mortality (hazard ratio, 1.28; 95% confidence interval, 1.10-1.50; <i>P</i> = .002). <h3>Conclusions</h3> High-volume centers were associated with superior survival and improved perioperative outcomes following LVAD explant-OHT.

Authors

Institutions

Publication Details

Journal
JTCVS Open
Published
2025-11-20
DOI
https://doi.org/10.1016/j.xjon.2025.10.036
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High-volume centers achieve superior outcomes in left ventricular assist device explant-heart transplantation

Amy Tang, Michael E. Halkos, Konstantinos S. Mylonas, Muath Bishawi et al.
JTCVS Open
Mechanical Circulatory Support Devices
article

High-volume centers achieve superior outcomes in left ventricular assist device explant-heart transplantation

Amy Tang, Michael E. Halkos, Konstantinos S. Mylonas, Muath Bishawi, Sharan Randhawa, Joshua L. Chan, Humza Naqvi, Mani A. Daneshmand, Sally El Sammak, Catherine McGeoch, Clayton J. Rust, Reshma Kodimerla
article en

Abstract

<h2>Abstract</h2><h3>Background</h3> Left ventricular assist device <b>(</b>LVAD) explantation at the time of orthotopic heart transplantation (OHT) carries increased perioperative risks. This study examined whether institutional operative volume influences outcomes following LVAD explant-OHT in a contemporary national cohort. <h3>Methods</h3> Adult patients who underwent LVAD explantation with OHT between 2011 and 2024 were identified in the Organ Procurement and Transportation Network/United Network for Organ Sharing registry. Using a rank-order method based on surgical volume, centers were stratified as either high volume or low volume. The primary outcome was 1-year survival; secondary outcomes included graft failure, ischemic time, dialysis, stroke, and hospital length of stay. Kaplan-Meier and Cox regression analyses were performed to assess survival and predictors of mortality. <h3>Results</h3> A total of 2863 patients across 121 centers were analyzed. Eight high-volume centers performed 31.3% (897 cases) of all LVAD explant-OHTs. Baseline characteristics, including heart failure etiology and LVAD device type, were similar in the 2 groups. High-volume centers demonstrated decreased ischemic time (mean, 3.1 ± 1.3 hours vs 3.5 ± 1.4 hours; <i>P</i> < .001), a lower rate of postoperative dialysis (12.7% vs 15.4%; <i>P</i> = .023), and shorter length of stay (mean, 22.8 ± 26.6 days vs 25.9 ± 31.3 days; <i>P</i> = .006) compared to low-volume centers. Graft failure was less common at high-volume centers (24.2% vs 28.8%; <i>P</i> = .011). One-year survival rate (81.6% vs 76.1%; <i>P</i> = .001) and median survival (4.93 years vs 4.00 years; <i>P</i> = .018) were greater at high-volume centers. Multivariable analysis identified low-volume center status as an independent predictor of higher mortality (hazard ratio, 1.28; 95% confidence interval, 1.10-1.50; <i>P</i> = .002). <h3>Conclusions</h3> High-volume centers were associated with superior survival and improved perioperative outcomes following LVAD explant-OHT.

JTCVS OpenVol. 29
Emory University (US)
Emory University, National Institutes of Health, National Center for Advancing Translational Sciences
Openalex Percentile: Top 65%
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.